Search Full Text
Now showing items 1-1 of 1
Effects of CDK4/6 Inhibition on Progression of Early Stage Breast Cancer
(Georgetown University, 2019)
Here we demonstrate the efficacy of palbociclib in targeting the cell cycle kinase CDK4/6 and canonical pathways downstream in both normal breast epithelial (MCF10A) and early stage breast cancer cells (MCFDCIS) resulting ...